Massey offers microsurgical breast reconstruction
Santosh Kale, MD, plastic surgeon in the Division of Plastic and Reconstructive Surgery at VCU Medical Center and VCU Massey Cancer Center, is one of a few plastic surgeons in the Richmond area to offer microsurgical breast reconstruction. Because of the high level of skill and specialized equipment required to perform microsurgery, this form of breast reconstruction is typically only offered at specialized medical centers such as Massey.
Massey scored highest in Virginia for cancer care by U.S. News for third year
For the third year in a row, VCU Massey Cancer Center was the top scoring hospital in Virginia providing high-performing cancer care in U.S. News & World Report’s annual Best Hospitals list. Massey received the best score in cancer care of the 24 Virginia hospitals that made the list of the nearly 130 total hospitals in the state. Additionally, VCU Medical Center, which includes Massey’s oncology patient care, was ranked the best hospital in the Richmond metro area, marking the fourth consecutive year the hospital has led in the area.
Massey physician co-led landmark research that establishes a new standard of care for young women with hormone-sensitive breast cancer
VCU Massey Cancer Center physician-researcher Charles Geyer, M.D., co-authored practice-changing, international research on breast cancer that this weekend was presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and published online in the New England Journal of Medicine. This landmark study is the first to demonstrate that taking exemestane while blocking ovarian function reduces cancer recurrence in young women with hormone-receptive breast cancer.
Longtime Massey nurse wins distinguished award
For 15 years, Kevin Brigle, Ph.D., A.N.P., has served VCU Massey Cancer Center as a nurse practitioner. Working in the Hematological Malignancy Clinic, Brigle focuses on treating patients with leukemia, lymphoma, multiple myeloma and other blood borne cancers. Recently, Brigle was awarded the Oncology Nursing Society (ONS) Pearl Moore “Making a Difference” Award.
New therapy for blood cancers developed
Clinical researchers at VCU Massey Cancer Center have successfully completed a phase 1 clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a phase 2 clinical trial to test the safety and effectiveness of the new therapy.